Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$483.12 USD
+2.03 (0.42%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $483.11 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Intuitive Surgical, Inc. has a PEG ratio of 4.10 compared to the Medical - Instruments industry's PEG ratio of 2.25.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ISRG 483.12 +2.03(0.42%)
Will ISRG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ISRG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ISRG
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
ISRG's Gross Margin Falls on Product Transition and Trade Pressures
ISRG: What are Zacks experts saying now?
Zacks Private Portfolio Services
EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down
Can ISRG's Strong Q2 Procedure Volume Translate Into Durable EPS Upside?
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
Other News for ISRG
Franklin U.S. Focused Growth SMA Q2 2025 Commentary
Franklin DynaTech SMA Q2 2025 Commentary
BME: The Resilient Income Investment Of The Healthcare Industry
Intuitive Surgical (ISRG) Shares Dip Despite Strong Q2 Performance
12 out of 12 healthcare firms top revenue estimates this week: Earnings Scorecard